Vista Current Coverage

All Healthcare/Biotech Articles

Shares of Gene Therapy Firm AveXis Surge on Novartis’ Buyout

Novartis (NVS) has agreed to pay $218/share for gene therapy firm AveXis (AVXS), a 88% premium to April 6th’s closing price. This gives Novartis, a Swiss drug giant, several treatments for rare diseases based on gene therapy. Vas Narasimhan stated on a conference call, “We’re in...

Caruso Announces Retirement From Johnson & Johnson

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Dominic J. Caruso, Executive Vice President, Chief Financial Officer of Johnson & Johnson has announced...

Atossa Genetics Expands Breast Health Program With Mens’ Initiative

Gynecomastia is male breast enlargement and accompanying pain. It is the most common male breast disorder and is caused by a hormone imbalance where testosterone is low compared to estrogen. In prostate cancer treatment, testosterone is suppressed resulting is higher estrogen levels that usually triggers...